Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.5 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0019 | 0.5 | 0.5 |
Echinococcus granulosus | dna polymerase eta | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Schistosoma mansoni | DNA polymerase eta | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.5 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.5 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.5 | 0.5 |
Leishmania major | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0019 | 0.5 | 0.5 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.5 | 0.5 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.5 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.5 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.5 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.5 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.5 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.5 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.